Luciano de Moura Santos

Luciano de Moura Santos

Auto-generated profile, based on publicly available information

Luciano de Moura Santos

Hospital Santa Lúcia, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
WGWelingson Vanucci Negreiros Guimarães
Welingson Vanucci Negreiros Guimarães
PNPedro Felipe Gomes Nicz
Pedro Felipe Gomes Nicz
HGHector M. Garcia-Garcia
Hector M. Garcia-Garcia
AAAlexandre Abizaid
Alexandre Abizaid
LSLuciano de Moura Santos
Luciano de Moura Santos
CCCarlos Campos
Carlos Campos

1 August 2024 in Journal of Invasive Cardiology
Verified
Journal Article
Closed access
LSLuciano Santos
Luciano Santos
WJWenderval Carvalho Júnior
Wenderval Carvalho Júnior
MRMarcelo Ribeiro
Marcelo Ribeiro
MLMaria Lopes
Maria Lopes
ESEduardo Silva
Eduardo Silva
CCCarlos Campos
Carlos Campos
Fractional flow reserve (FFR) has been established as the gold standard in the physiological assessment of coronary obstructions severity. However, the need to insert an intracoronary pressure guidewire is a factor that limits its use. Quantitative flow ratio (QFR) is a method that infers the value of FFR from 3-dimensional quantitative coronary angiography (3D-QCA), eliminating the use of a pressure wire and coronary hyperemia. The present study aims to evaluate the diagnostic accuracy of QFR and 3D-QCA in comparison with FFR for the identification of significant obstructive coronary lesions (FFR ≤.80) and the feasibility to assess QFR in a cohort of patients without dedicated angiographic acquisition. Original Research from Journal of Invasive Cardiology. Fractional Flow Reserve quantitative coronary angiography quantitative flow ratio

1 January 2026 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
PCPedro Calomeni
Pedro Calomeni
FBFernando Bernardi
Fernando Bernardi
FSFabio Sandoli
Fabio Sandoli
MAMarcella Sousa Abizaid
Marcella Sousa Abizaid
FBFrancisco Ribeiro Barbosa
Francisco Ribeiro Barbosa
HRHenrique Barbosa Ribeiro
Henrique Barbosa Ribeiro
Background: Bicuspid aortic valve (BAV) is a significant risk factor for aortic stenosis (AS). Yet, the outcomes of transcatheter aortic valve implantation (TAVI) remain unclear, as most randomized trials excluded such patients. Furthermore, most published evidence on TAVI in BAV comes from high-income countries, which may not reflect realities of underserved populations. Objectives: Evaluate temporal trends, procedural, and in-hospital outcomes between BAV and tricuspid aortic valve (TAV) patients. Methods: Retrospective observational study based on a Brazilian multicenter registry of TAVI patients between January 2009 and December 2021. We performed propensity score matching to adjust comparisons. A p-value <0.05 was considered statistically significant for all analyses. Results: Among 2,426 patients from 25 centers, 111 had BAV. TAVI procedures increased over time in both groups. After one-to-three matching, 90 BAV and 243 TAV patients were included. No significant differences were observed in rates of major vascular complications (4% vs. 5%; p=0.99), major or life-threatening bleeding (10% vs. 6%; p=0.34), stroke (2% vs. 0.4%; p=0.37), or in-hospital mortality (7% vs. 3%; p=0.21). Over time, there was a significant reduction in in-hospital mortality (p<0.01) and major procedural complications (p<0.01 for vascular, bleeding, and stroke events), regardless of valve type. Conclusion: During the study period, annual TAVI procedures increased in both BAV and TAV patients, although the prevalence of BAV remained relatively low. No significant differences were observed in procedural or clinical outcomes between the propensity-matched groups. Both valve types showed reductions in procedural complications and in-hospital mortality over time.

1 January 2024 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
FBFernando Luiz de Melo Bernardi
Fernando Luiz de Melo Bernardi
AAAlexandre A. Abizaid
Alexandre A. Abizaid
FSFabio Sandoli
Fabio Sandoli
PLPedro A. Lemos
Pedro A. Lemos
DSDimytri Alexandre Alvim de Siqueira
Dimytri Alexandre Alvim de Siqueira
HRHenrique Ribeiro
Henrique Ribeiro
Resumo Fundamento Dados robustos sobre a curva de aprendizagem (LC) da substituição da válvula aórtica transcateter (TAVR) são escassos nos países em desenvolvimento. Objetivo Avaliar a LC da TAVR no Brasil ao longo do tempo. Métodos Analisamos dados do registro brasileiro de TAVR de 2008 a 2023. Pacientes de cada centro foram numerados cronologicamente em número sequencial de caso (NSC). A LC foi realizada usando um spline cúbico restrito ajustado para o EuroSCORE-II e o uso de próteses de nova geração. Ainda, os desfechos hospitalares foram comparados entre grupos definidos de acordo com o nível de experiência, com base no NSC: 1º ao 40º caso (experiência inicial), 41º ao 80º caso (experiência básica), 81º ao 120º caso (experiência intermediária) e 121º caso em diante (experiência alta). Análises adicionais foram conduzidas de acordo com o número de casos tratados antes de 2014 (>40 e ≤40 procedimentos). O nível de significância adotado foi p <0,05. Resultados Foram incluídos 3194 pacientes de 25 centros. A idade média foi 80,7±8,1 anos e o EuroSCORE II médio foi 7±7,1. A análise da LC demonstrou uma queda na mortalidade hospitalar ajustada após o tratamento de 40 pacientes. Um patamar de nivelamento na curva foi observado após o caso 118. A mortalidade hospitalar entre os grupos foi 8,6%, 7,7%, 5,9%, e 3,7% para experiência inicial, básica, intermediária e alta, respectivamente (p<0,001). A experiência alta foi preditora independente de mortalidade mais baixa (OR 0,57, p=0,013 vs. experiência inicial). Centros com baixo volume de casos antes de 2014 não mostraram uma redução significativa na probabilidade de morte com o ganho de experiência, enquanto centros com alto volume de casos antes de 2014 apresentaram uma melhora contínua após o caso de número 10. Conclusão Observou-se um fenômeno de LC para a mortalidade hospitalar do TAVR no Brasil. Esse efeito foi mais pronunciado em centros que trataram seus 40 primeiros casos antes de 2014 que naqueles que o fizeram após 2014.

26 April 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
LSLuciano de Moura Santos
Luciano de Moura Santos
LLLarissa Santos Luz
Larissa Santos Luz
VBVinicius Lelis Bastos
Vinicius Lelis Bastos
TBTulio Assunção Barcelos
Tulio Assunção Barcelos
FAFrederico André Alves Abreu
Frederico André Alves Abreu
WCWenderval Borges Carvalho
Wenderval Borges Carvalho
Background: For individuals with pure aortic regurgitation (AR), transcatheter aortic valve implantation (TAVI) is cautiously recommended only for those with a high or prohibitive surgical risk. We aimed to describe the results of a case series of transcatheter implantation of a balloon-expandable aortic valve bioprosthesis (BEV) for the treatment of noncalcified native valve AR.Methods: From February 2022–November 2022, we performed TAVI in patients with severe pure AR. Cases were indicated on the basis of symptoms, high/prohibitive surgical risk, or patient refusal of conventional treatment.Results: Five patients underwent successful TAVI. The mean age was 81.9 ± 6.6 years, 3 (60%) female and 5 (100%) in NYHA class III or IV. The baseline echocardiogram showed an ejection fraction of 49.0 ± 10.6% and left ventricular end-systolic diameter 28.5 ± 4.7 mm/m². The average area of the aortic annulus was 529.1 ± 47.0mm² and the area oversizing index was 17.6 ± 1.2%. In the 30-day follow-up, there were no cases of prosthesis embolization, annulus rupture, stroke, acute myocardial infarction, acute renal failure, hemorrhagic complication or death. One patient required a permanent pacemaker and another had a minor vascular complication. The clinical follow-up were 19.8 months (16.7–21.8). During this period, all patients remained alive and in NYHA class I or II. One of the patients developed a moderate paravalvular leak.Conclusion: TAVI with a BEV proved to be safe and effective in this small case series of patients with noncalcified native valve AR in a follow-up longer than 1 year.

1 April 2024 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
LSLuciano de Moura Santos
Luciano de Moura Santos
CCCarlos Campos
Carlos Campos
HGHector Manuel Garcia‐Garcia
Hector Manuel Garcia‐Garcia
RGRoger Renault Godinho
Roger Renault Godinho
MLMaria Antonieta Albanez Medeiros Lopes
Maria Antonieta Albanez Medeiros Lopes
AAAlexandre Antônio Cunha Abizaid
Alexandre Antônio Cunha Abizaid